Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Clinical implementation in the diagnostic process

Nature Reviews Neurology

Volumn 11, Issue 8, 2015, Pages 471-482

  Rovira, Álex ^a   Wattjes, Mike P ^b   Tintoré, Mar ^a   Tur, Carmen ^a   Yousry, Tarek A ^c   Sormani, Maria P ^d   De Stefano, Nicola ^e   Filippi, Massimo ^f   Auger, Cristina ^a   Rocca, Maria A ^f   Barkhof, Frederik ^b   Fazekas, Franz ^g   Kappos, Ludwig ^h   Polman, Chris ^b   Miller, David ^c   Montalban, Xavier ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF SIENA   (Italy)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CONSENSUS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEALTH CARE ORGANIZATION; HUMAN; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROLOGIST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PERSONAL EXPERIENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOLOGIST; SPINAL CORD; STANDARDIZATION; BRAIN DISEASES; CLINICAL PROTOCOL; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; MEDICAL RECORD; PROCEDURES; SPINAL CORD DISEASES;

CONTRAST MEDIUM;

BRAIN DISEASES; CLINICAL PROTOCOLS; CONSENSUS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; HUMANS; MAGNETIC RESONANCE IMAGING; MEDICAL RECORDS; MULTIPLE SCLEROSIS; SPINAL CORD DISEASES;

EID: 84938959171     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2015.106     Document Type: Article

References (132)

1. Filippi, M. et al. Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group. J. Magn. Reson. Imaging 21, 669-675 (2005).
2. O'Connor, P. et al. Key issues in the diagnosis and treatment of multiple sclerosis. An overview. Neurology 59 (Suppl. 3) S1-S33 (2002).
3. Verhey, L. H. & Sled, J. G. Advanced magnetic resonance imaging in pediatric multiple sclerosis. Neuroimaging Clin. N. Am. 23, 337-354 (2013).
4. Poser, C. M. et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231 (1983).
5. McDonald, W. I. et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50, 121-127 (2001).
6. Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 58, 840-846 (2005).
7. Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69, 292-302 (2011).
8. Goodin, D. S. & Bates, D. Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode. Mult. Scler. 15, 1175-1182 (2009).
9. Charil, A. et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol. 5, 841-852 (2006).
10. Miller, D. H. et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult. Scler. 14, 1157-1174 (2008).
11. Swanton, J. K. et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol. 6, 677-686 (2007).
12. Tur, C. et al. Very early scans for demonstrating dissemination in time in multiple sclerosis. Mult. Scler. 14, 631-635 (2008).
13. Rovira, A. et al. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch. Neurol. 66, 587-592 (2009).
14. Montalban, X. et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology 74, 427-434 (2010).
15. Solomon, A. J., Klein, E. P. & Bourdette, D. "Undiagnosing" multiple sclerosis: the challenge of misdiagnosis in MS. Neurology 78, 1986-1991 (2012).
16. Tintoré, M. et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 70, 1079-1083 (2008).
17. Dobson, R., Ramagopalan, S., Davis, A. & Giovannoni, G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-Analysis of prevalence, prognosis and effect of latitude. J. Neurol. Neurosurg. Psychiatry 84, 909-914 (2013).
18. Kelly, S. B. et al. A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis. Mult. Scler. 19, 1095-1100 (2013).
19. Dalton, C. M. et al. Spinal cord MRI in clinically isolated optic neuritis. J. Neurol. Neurosurg. Psychiatry. 74, 1577-1580 (2003).
20. Montalban, X. et al. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Mult. Scler. 15, 1459-1465 (2009).
21. Sadaka, Y. et al. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann. Neurol. 72, 211-223 (2012).
22. Kornek, B. et al. Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome. Mult. Scler. 18, 1768-1774 (2012).
23. Huh, S. Y. et al. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult. Scler. 20, 695-704 (2014).
24. Patrucco, L., Rojas, J. I., Miguez, J. S. & Cristiano, E. Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes. Mult. Scler. 19, 1297-1301 (2013).
25. Pestalozza, I. F. et al. Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome. Mult. Scler. 11, 390-394 (2005).
26. Lebrun, C. et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch. Neurol. 66, 841-846 (2009).
27. Jacobi, C. et al. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time. Eur. J. Neurol. 15, 1359-1364 (2008).
28. Fernando, K. T. et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 127, 1361-1369 (2004).
29. Wattjes, M. P. et al. High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria. J. Neurol. 255, 56-63 (2008).
30. Wattjes, M. P. et al. Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis. Neuroradiology 50, 123-129 (2008).
31. Rovaris, M. et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-Term follow-up study. Brain 126, 2323-2332 (2003).
32. Agosta, F. et al. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 129, 2620-2627 (2006).
33. Filippi, M. & Agosta, F. Imaging biomarkers in multiple sclerosis. J. Magn. Reson. Imaging 31, 770-788 (2010).
34. Rovaris, M. et al. A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS. J. Neurol. 255, 1209-1214 (2008).
35. Inglese, M. et al. Magnetization transfer and diffusion tensor MR imaging of acute disseminated encephalomyelitis. AJNR Am. J. Neuroradiol. 23, 267-272 (2002).
36. Benedetti, B. et al. Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI. Neurology 67, 161-163 (2006).
37. Yu, C. et al. Pathogenesis of normal-Appearing white matter damage in neuromyelitis optica: diffusion-Tensor MR imaging. Radiology 246, 222-228 (2008).
38. Barcella, V. et al. Evidence for retrochiasmatic tissue loss in Leber's hereditary optic neuropathy. Hum. Brain Mapp. 31, 1900-1906 (2010).
39. Kang, H. et al. Application and a proposed modification of the McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes. Mult. Scler. 20, 458-463 (2014) (2010).
40. Sastre-Garriga, J. et al. Specificity of Barkhof criteria in predicting conversion to multiple sclerosis when applied to clinically isolated brainstem syndromes. Arch. Neurol. 61, 222-224 (2004).
41. Mitjana, R. et al. Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes. Mult. Scler. 20, 1471-1477 (2014).
42. Wuerfel, J. et al. Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult. Scler. 18, 1592-1599 (2012).
43. Tallantyre, E. C. et al. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 70, 2076-2078 (2008).
44. Hammond, K. E. et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann. Neurol. 64, 707-713 (2008).
45. Tallantyre, E. C. et al. A comparison of 3 T and 7 T in the detection of small parenchymal veins within MS lesions. Invest. Radiol. 44, 491-494 (2009).
46. Haacke, E. M. et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J. Magn. Reson. Imaging 29, 537-544 (2009).
47. Tallantyre, E. C. et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology 76, 534-539 (2011).
48. Sinnecker, T. et al. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 79, 708-714 (2012).
49. Kilsdonk, I. D. et al. Improved differentiation between MS and vascular brain lesions using FLAIR∗ at 7 Tesla. Eur. Radiol 24, 841-849 (2014).
50. Haacke, E. M., Xu, Y., Cheng, Y. C. & Reichenbach, J. R. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 52, 612-618 (2004).
51. Sati, P. et al. FLAIR∗: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins. Radiology 265, 926-932 (2012).
52. Grabner, G. et al. Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI. J. Magn. Reson. Imaging 33, 543-549 (2011).
53. Absinta, M. et al. Seven-Tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process. Ann. Neurol. 74, 669-678 (2013).
54. Hagemeier, J. et al. Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study. J. Magn. Reson. Imaging 36, 73-83 (2012).
55. Bian, W. et al. A serial in vivo 7 T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult. Scler. 19, 69-75 (2013).
56. Bagnato, F. et al. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 134, 3602-3615 (2011).
57. Hametner, S. et al. Iron and neurodegeneration in the multiple sclerosis brain. Ann. Neurol. 74, 848-861 (2013).
58. Kau, T. et al. The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis? Eur. Radiol. 23, 1956-1962 (2013).
59. Luo, J. et al. Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions. Mult. Scler. 20, 349-355 (2014).
60. Sati, P. et al. Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis. Mult. Scler. 20, 1464-1470 (2014).
61. Hagemeier, J. et al. Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders. AJNR Am. J. Neuroradiol. 35, 1916-1923 (2014).
62. Calabrese, M. et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch. Neurol. 64, 1416-1422 (2007).
63. Geurts, J. J. et al. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 236, 254-260 (2005).
64. Wattjes, M. P. et al. Double inversion recovery brain imaging at 3 T: diagnostic value in the detection of multiple sclerosis lesions. AJNR Am. J. Neuroradiol. 28, 54-59 (2007).
65. Simon, B. et al. Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur. Radiol. 20, 1675-1683 (2010).
66. Geurts, J. J. et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 76, 418-424 (2011).
67. Nelson, F. et al. Intracortical lesions by 3 T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis. Mult. Scler. 17, 1122-1129 (2011).
68. Sethi, V. et al. Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J. Neurol. Neurosurg. Psychiatry 83, 877-882 (2012).
69. Nelson, F., Poonawalla, A., Hou, P., Wolinsky, J. S. & Narayana, P. A. 3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult. Scler. 14, 1214-1219 (2008).
70. de Graaf, W. L. et al. Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR. Eur. Radiol. 22, 221-231 (2012).
71. Kilsdonk, I. D. et al. Multicontrast MR imaging at 7 T in multiple sclerosis: highest lesion detection in cortical gray matter with 3D-FLAIR. AJNR Am. J. Neuroradiol. 34, 791-796 (2013).
72. Filippi, M. et al. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology 75, 1988-1994 (2010).
73. Giorgio, A. et al. Cortical lesions in radiologically isolated syndrome. Neurology 77, 1896-1899 (2011).
74. Sethi, V. et al. MS cortical lesions on DIR: not quite what they seem? PLoS One 8, e78879 (2013).
75. Quinn, M. P., Kremenchutzky, M. & Menon, R. S. Venocentric lesions: an MRI marker of MS? Front. Neurol. 4, 98 (2013).
76. Wattjes, M. P. et al. Imaging of inflammatory lesions at 3.0 Tesla in patients with clinically isolated syndromes suggestive of multiple sclerosis: a comparison of fluid-Attenuated inversion recovery with T2 turbo spin-echo. Eur. Radiol. 16, 1494-1500 (2006).
77. Wattjes, M. P. & Barkhof, F. High field MRI in the diagnosis of multiple sclerosis: high field-high yield? Neuroradiology 51, 279-292 (2009).
78. Miller, D. H. et al. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann. Neurol. 56, 273-278 (2004).
79. Simon, J. H. et al. Standardized MR imaging protocol for multiple sclerosis: consortium of MS centers consensus guidelines. AJNR Am. J. Neuroradiol. 65, 1447-1454 (2006).
80. Lövblad, K. O. et al. MR imaging in multiple sclerosis: review and recommendations for current practice. AJNR Am. J. Neuroradiol. 31, 983-989 (2010).
81. Filippi, M. et al. Guidelines from the Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients. Neurol. Sci. 34, 2085-2093 (2013).
82. Molyneux, P. D. et al. Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility. Neuroradiology 41, 882-888 (1999).
83. Rennard, D. et al. An MRI review of acquired corpus callosum lesions. J. Neurol. Neurosurg. Psychiatry. 85, 1041-1048 (2014).
84. Bink, A. et al. Detection of lesions in multiple sclerosis by 2D FLAIR and single-slab 3D FLAIR sequences at 3.0 T: initial results. Eur. Radiol. 16, 1104-1110 (2006).
85. Moraal, B. et al. Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis. Eur. Radiol. 18, 2311-2320 (2008).
86. Barkhof, F., Pouwels, P. J. & Wattjes, M. P. The Holy Grail in diagnostic neuroradiology: 3 T or 3D? Eur. Radiol. 21, 449-456 (2011).
87. Schmidt, P. et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. Neuroimage 59, 3774-3783 (2012).
88. Uysal, E., Erturk, S. M., Yildirim, H., Seleker, F. & Basak, M. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions. AJR Am. J. Roentgenol. 188, 697-702 (2007).
89. Kataoka, H., Taoka, T. & Ueno, S. Early contrast-enhanced magnetic resonance imaging with fluid-Attenuated inversion recovery in multiple sclerosis. J. Neuroimaging 19, 246-249 (2009).
90. Filippi, M. et al. Sensitivity of delayed gadolinium-enhanced MRI in multiple sclerosis. Acta Neurol. Scand. 95, 331-334 (1997).
91. Silver, N. C. et al. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain 120, 1149-1161 (1997).
92. Alkan, O., Kizilkiliç, O., Yildirim, T. & Alibek, S. Comparison of contrast-enhanced T1-weighted FLAIR with BLADE, and spin-echo T1-weighted sequences in intracranial MRI. Diagn. Interv. Radiol. 15, 75-80 (2009).
93. Fischbach, F. et al. Efficacy of contrast medium use for neuroimaging at 3.0 T: utility of IR-FSE compared to other T1-weighted pulse sequences. J. Comput. Assist. Tomogr. 29, 499-505 (2005).
94. Runge, V. M. et al. T1-weighted imaging of the brain at 3 Tesla using a 2-dimensional spoiled gradient echo technique. Invest. Radiol. 41, 68-75 (2006).
95. Hodel, J. et al. Accuracy of postcontrast 3D turbo spin-echo MR sequence for the detection of enhanced inflammatory lesions in patients with multiple sclerosis. AJNR Am. J. Neuroradiol. 35, 519-523 (2014).
96. Crombé, A. et al. MS Lesions are better detected with 3D T1 gradient-echo than with 2D T1 spin-echo gadolinium-enhanced imaging at 3 T. AJNR Am. J. Neuroradiol. 36, 501-507 (2015).
97. Schaefer, P. W., Grant, P. E. & Gonzalez, R. G. Diffusion-weighted MR imaging of the brain. Radiology 217, 331-345 (2000).
98. Eisele, P. et al. Reduced diffusion in a subset of acute MS lesions: a serial multiparametric MRI study. AJNR Am. J. Neuroradiol. 33, 1369-1373 (2012).
99. Rovira, A. et al. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am. J. Neuroradiol. 23, 989-994 (2002).
100. Balashov, K. E. & Lindzen, E. Acute demyelinating lesions with restricted diffusion in multiple sclerosis. Mult. Scler. 18, 1745-1753 (2012).
101. Hannoun, S. et al. Weekly multimodal MRI follow-up of two multiple sclerosis active lesions presenting a transient decrease in ADC. Brain Behav. 5, e00307 (2015).
102. Miller, D. H., Barkhof, F. & Nauta, J. J. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 116, 1077-1094 (1993).
103. Gallagher, H. L, MacManus, D. G., Webb, S. L. & Miller, D. H. A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis. J. Magn. Reson. Imaging 7, 439-441 (1997).
104. Moraal, B. et al. Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology 255, 154-163 (2010).
105. Battaglini, M. et al. Automated identification of brain new lesions in multiple sclerosis using subtraction images. J. Magn. Reson. Imaging 39, 1543-1549 (2014).
106. Diez, Y. et al. Intensity based methods for brain MRI longitudinal registration. A study on multiple sclerosis patients. Neuroinformatics 12, 365-379 (2014).
107. Miller, D. H., Barkhof, F., Frank, J. A., Parker, G. J. & Thompson, A. J. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125, 1676-1695 (2002).
108. Anderson, V. M., Fox, N. C. & Miller, D. H. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J. Magn. Reson. Imaging 23, 605-618 (2006).
109. Bermel, R. A. & Bakshi, R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol. 5, 158-170 (2006).
110. Shiee, N. et al. Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS ONE 7, e37049 (2012).
111. De Stefano, N. et al. Clinical relevance of brain volume measures in multiple sclerosis. CNS Drugs 28, 147-156 (2014).
112. Pérez-Miralles, F. et al. Clinical impact of early brain atrophy in clinically isolated syndromes. Mult. Scler. 19, 1878-1886 (2013).
113. Hofstetter, L. et al. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis. Mult. Scler. 20, 202-213 (2014).
114. Enzinger, C. et al. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 64, 1704-1711 (2005).
115. Vrenken, H. et al. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J. Neurol. 260, 2458-2471 (2013).
116. Bot, J. C. et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal cord MRI examination. Neurology 62, 226-233 (2004).
117. Okuda, D. T. et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 76, 686-692 (2011).
118. Lycklama, G. et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol. 2, 555-562 (2003).
119. Lycklama à Nijeholt, G. J. et al. Sagittal MR of multiple sclerosis in the spinal cord: fast versus conventional spin-echo imaging. AJNR Am. J. Neuroradiol. 19, 355-360 (1998).
120. Stankiewicz, J. M. et al. Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study. J. Neurol. Sci. 279, 99-105 (2009).
121. Bot, J. C. & Barkhof, F. Spinal-cord MRI in multiple sclerosis: conventional and nonconventional MR techniques. Neuroimaging Clin. N. Am. 19, 81-99 (2009).
122. Bot, J. C. et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 223, 46-56 (2002).
123. Sombekke, M. H. et al. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology 80, 69-75 (2013).
124. Gass, A. et al. MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis. Lancet Neurol. 14, 443-454 (2015).
125. Philpott, C. & Brotchie, P. Comparison of MRI sequences for evaluation of multiple sclerosis of the cervical spinal cord at 3 T. Eur. J. Radiol. 80, 780-785 (2011).
126. Bot, J. C. et al. Comparison of a conventional cardiac-Triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosis. Eur. Radiol. 10, 753-758 (2000).
127. Poonawalla, A. H., Hou, P., Nelson, F. A., Wolinsky, J. S. & Narayana, P. A. Cervical spinal cord lesions in multiple sclerosis: T1-weighted inversion-recovery MR imaging with phase-sensitive reconstruction. Radiology 246, 258-264 (2008).
128. Thorpe, J. W. et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46, 373-378 (1996).
129. European Society of Radiology (ESR). Good practice for radiological reporting. Guidelines from the European Society of Radiology (ESR). Insights Imaging 2, 93-96 (2011).
130. Bosmans, J. M., Weyler, J. J., De Schepper, A. M. & Parizel, P. M. The radiology report as seen by radiologists and referring clinicians: results of the COVER and ROVER surveys. Radiology 259, 184-195 (2011).
131. Kahn, C. E. Jr et al. Toward best practices in radiology reporting. Radiology 252, 852-856 (2009).
132. Dunnick, N. R., Applegate, K. E. & Arenson, R. L. Quality-A radiology imperative: report of the 2006 Intersociety Conference. J. Am. Coll. Radiol. 4, 156-161 (2007).